CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 23, 2018—CAP TODAY is hosting a webinar titled “Endeavor to leave no patient behind: next-generation sequencing (NGS) in routine NSCLC biomarker testing” on Wednesday, March 28, 1 PM ET.
Boaz Kurtis, MD, medical director of Cancer Genetics, Inc., will discuss how to practice precision oncology based on fast-changing guidelines and to ensure even challenging samples get tested to achieve best outcomes for as many NSCLC patients as possible. Dr. Kurtis will present Cancer Genetics’ testing model, case studies, and lessons learned and will answer questions from webinar attendees.
This hourlong webinar will be moderated by CAP TODAY publisher Bob McGonnagle. Registration is free of charge at www.captodayonline.com/032818webinar.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher.